Anúncio
Anúncio

PHIO

PHIO logo

Phio Pharmaceuticals Corp. Common Stock

1.20
USD
Patrocinado
+0.05
+4.52%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

1.19

-0.01
-0.67%

Relatórios de Lucros PHIO

Rácio de surpresa positiva

PHIO separação 23 de 29 últimas estimativas.

79%

Próximo Relatório

Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.34
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-22.73%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-60.00%

Phio Pharmaceuticals Corp. Common Stock earnings per share and revenue

On 13 de nov. de 2025, PHIO reported earnings of -0.44 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 4.14% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -9.09% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an diminuir of -22.73% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Phio Pharmaceuticals Corp. Common Stock reported EPS of -$0.44, beating estimates by 4.14%, and revenue of $0.00, 0% as expectations.
The stock price moved down -9.09%, changed from $1.43 before the earnings release to $1.30 the day after.
The next earning report is scheduled for 30 de mar. de 2026.
Based on 4 analistas, Phio Pharmaceuticals Corp. Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio